Renegade UxS ApS: Financial statements 2024
CVR: 44599570
Source: annual report 2024, Danish Business Authority
26/01/2024 – 31/12/2024
Renegade UxS ApS (CVR 44599570) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,288,569 and a net result of DKK 3,363,829. Equity in the 2024 report amounted to DKK 3,403,829. The solvency ratio was 12.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 4,288,569
- Profit/Loss
- DKK 3,363,829
- Equity
- DKK 3,403,829
- Total Assets
- DKK 27,545,706
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
On April 25, 2024, the company changed its name from Remode Medical ApS to Renegade UxS ApS.
As of January 26, 2024, Thomas Have is registered as director of Renegade UxS ApS.
As of January 26, 2024, Dennis Sobol Mikkelsen is registered as director of Renegade UxS ApS.
Renegade UxS ApS was founded on January 26, 2024.
About Renegade UxS ApS
Renegade UxS ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2024. The company is registered under the industry Fremstilling af civile luft- og rumfartøjer o.lign.. The company was previously named Remode Medical ApS. The management consists of Dennis Sobol Mikkelsen and Thomas Have. The company is owned by Tier One Nordic ApS. The company has 27 employees (2026). In 2025, the company reported a gross profit of DKK 85,302,269 and a net result of DKK 65,900,568 compared with DKK 3,363,829 the year before. Equity in the 2025 report amounted to DKK 68,004,397.